Skip to main content
Top
Published in: BMC Health Services Research 1/2022

Open Access 01-12-2022 | Magnetic Resonance Imaging | Research

Diagnostic delay in soft tissue tumors: a single-center study of a university cancer center with a focus on health services research

Authors: Tobias M. Ballhause, Alonja Reiter, Alexander Korthaus, Karl-Heinz Frosch, Carsten W. Schlickewei, Matthias H. Priemel

Published in: BMC Health Services Research | Issue 1/2022

Login to get access

Abstract

Background

Lumps and soft tissue tumors (STT) are frequent reasons for consulting a physician. Most STT are benign, and lumps are not always associated with a tumor. MRI is the most advanced imaging modality to assist a provisional diagnosis of STT. Only a small fraction of STT is malignant, these soft tissue sarcomas are known for their aggressive growth.
The study aims to analyze the influence of the MRI report on the speed of treatment of patients with suspected STT.

Methods

This was a retrospective, longitudinal, single-center study from 2011–2020. We included adult patients who had biopsies or resections of masses suspicious for STT in MRI exams. MRI reports were classified as benign (I), intermediate/unclear (II), or malignant (III). For these cohorts, time was statistically analyzed from MRI scan to first contact with the University cancer center (UCC) and surgery. Furthermore, distance in kilometers from the patients´ home to the UCC was examined and compared to age and suspected malignancy.

Results

Three hundred two patients (♀130; ♂172) were included. Histologic analyses revealed 286 tumors. The average age of the patients was 54.7(SD: 16.2) years. Malignant tumors were more often suspected in older patients (p = 0.0098). Patients with a benign diagnosed tumor in MRI contacted the UCC after an average of 31.3 (SD: 47.8) days. In contrast, patients with suspicion of a malignant tumor contacted the UCC significantly earlier, after 14.1 days (SD: 17.1); p = 0.0098. Likewise, the time between first contact and biopsy/resection was 32.8 days (SD: 35.7) for suspiciously benign tumors, and potentially malignant tumors were treated significantly faster 14.8 (SD: 16.0) days; (p = 0.028). Patients traveled on average 47.5 km (range: 0.5–483) to contact a specialized physician at the UCC. Suspected degree of malignancy or patient´s age had no statistical influence on traveled distance.

Discussion

The treatment speed depended to a great extent on the suspected malignancy of the STT in the MRI report. The provisional diagnoses from the radiologist highly influenced the time delay between MRI scan and first contact to the UCC and surgical treatment. No discrimination of age or distance to the UCC was observed in this study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Trama A, et al. Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes. Cancer Epidemiol. 2019;59:258–64.CrossRef Trama A, et al. Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes. Cancer Epidemiol. 2019;59:258–64.CrossRef
2.
go back to reference Younger E, et al. Age-related sarcoma patient experience: results from a national survey in England. BMC Cancer. 2018;18(1):991.CrossRef Younger E, et al. Age-related sarcoma patient experience: results from a national survey in England. BMC Cancer. 2018;18(1):991.CrossRef
4.
go back to reference Church DJ, Krumme J, Kotwal S. evaluating soft-tissue lumps and bumps. Mo Med. 2017;4(114):289–94. Church DJ, Krumme J, Kotwal S. evaluating soft-tissue lumps and bumps. Mo Med. 2017;4(114):289–94.
5.
go back to reference Malinauskaite I, et al. Radiomics and machine learning differentiate soft-tissue lipoma and liposarcoma better than musculoskeletal radiologists. Sarcoma. 2020;2020:7163453.CrossRef Malinauskaite I, et al. Radiomics and machine learning differentiate soft-tissue lipoma and liposarcoma better than musculoskeletal radiologists. Sarcoma. 2020;2020:7163453.CrossRef
6.
go back to reference Weiss S, et al. Musculoskeletal soft-tissue sarcoma: quality assessment of initial mri reports shows frequent deviation from ESSR guidelines. Diagnostics (Basel). 2021;11(4):695.CrossRef Weiss S, et al. Musculoskeletal soft-tissue sarcoma: quality assessment of initial mri reports shows frequent deviation from ESSR guidelines. Diagnostics (Basel). 2021;11(4):695.CrossRef
7.
go back to reference Gage MM, et al. Sarcomas in the United States: Recent trends and a call for improved staging. Oncotarget. 2019;10(25):2462–74.CrossRef Gage MM, et al. Sarcomas in the United States: Recent trends and a call for improved staging. Oncotarget. 2019;10(25):2462–74.CrossRef
8.
go back to reference Baili P, et al. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study. Eur J Cancer. 2015;51(15):2120–9.CrossRef Baili P, et al. Age and case mix-standardised survival for all cancer patients in Europe 1999–2007: Results of EUROCARE-5, a population-based study. Eur J Cancer. 2015;51(15):2120–9.CrossRef
9.
go back to reference Seinen J, et al. Delays in the management of retroperitoneal sarcomas. Sarcoma. 2010;2010:702573.CrossRef Seinen J, et al. Delays in the management of retroperitoneal sarcomas. Sarcoma. 2010;2010:702573.CrossRef
10.
go back to reference Clark MA, Thomas JM. Delay in referral to a specialist soft-tissue sarcoma unit. Eur J Surg Oncol. 2005;31(4):443–8.CrossRef Clark MA, Thomas JM. Delay in referral to a specialist soft-tissue sarcoma unit. Eur J Surg Oncol. 2005;31(4):443–8.CrossRef
11.
go back to reference Gutierrez JC, et al. Should soft tissue sarcomas be treated at high-volume centers? an analysis of 4205 patients. Ann Surg. 2007;245(6):952–8.CrossRef Gutierrez JC, et al. Should soft tissue sarcomas be treated at high-volume centers? an analysis of 4205 patients. Ann Surg. 2007;245(6):952–8.CrossRef
12.
go back to reference Paszat L, et al. Processes and outcomes of care for soft tissue sarcoma of the extremities. Sarcoma. 2002;6(1):19–26.CrossRef Paszat L, et al. Processes and outcomes of care for soft tissue sarcoma of the extremities. Sarcoma. 2002;6(1):19–26.CrossRef
13.
go back to reference Koscielniak E, et. al. Weichteilsarkome S1-Leitlinie 2017/03/08. AWMF online. cited 2021 2021/05/04. AWMF Koscielniak E, et. al. Weichteilsarkome S1-Leitlinie 2017/03/08. AWMF online. cited 2021 2021/05/04. AWMF
15.
go back to reference Brouns F, Stas M, De Wever I. Delay in diagnosis of soft tissue sarcomas. Eur J Surg Oncol. 2003;29(5):440–5.CrossRef Brouns F, Stas M, De Wever I. Delay in diagnosis of soft tissue sarcomas. Eur J Surg Oncol. 2003;29(5):440–5.CrossRef
16.
go back to reference Buvarp Dyrop H, et al. Routes to diagnosis for suspected sarcoma: the impact of symptoms and clinical findings on the diagnostic process. Sarcoma. 2016;2016:8639272.CrossRef Buvarp Dyrop H, et al. Routes to diagnosis for suspected sarcoma: the impact of symptoms and clinical findings on the diagnostic process. Sarcoma. 2016;2016:8639272.CrossRef
17.
go back to reference Burningham Z, et al. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2(1):14.CrossRef Burningham Z, et al. The epidemiology of sarcoma. Clin Sarcoma Res. 2012;2(1):14.CrossRef
19.
go back to reference Panda KG, et al. Comparison between preoperative biopsy and post-excision histology results in sarcoma: experience at Chris Hani Baragwanath Academic Hospital, Johannesburg. South Africa S Afr J Surg. 2014;52(2):45–8.CrossRef Panda KG, et al. Comparison between preoperative biopsy and post-excision histology results in sarcoma: experience at Chris Hani Baragwanath Academic Hospital, Johannesburg. South Africa S Afr J Surg. 2014;52(2):45–8.CrossRef
20.
go back to reference Hoeber I, et al. Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors. Ann Surg Oncol. 2001;8(1):80–7.CrossRef Hoeber I, et al. Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors. Ann Surg Oncol. 2001;8(1):80–7.CrossRef
21.
go back to reference Weaver R, et al. The complexity of diagnosing sarcoma in a timely manner: perspectives of health professionals, patients, and carers in Australia. BMC Health Serv Res. 2020;20(1):711.CrossRef Weaver R, et al. The complexity of diagnosing sarcoma in a timely manner: perspectives of health professionals, patients, and carers in Australia. BMC Health Serv Res. 2020;20(1):711.CrossRef
22.
go back to reference Herbert A, et al. Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort. Lancet Child Adolesc Health. 2018;2(3):180–90.CrossRef Herbert A, et al. Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort. Lancet Child Adolesc Health. 2018;2(3):180–90.CrossRef
23.
go back to reference Li J, et al. Retaining rural doctors: doctors’ preferences for rural medical workforce incentives. Soc Sci Med. 2014;121:56–64.CrossRef Li J, et al. Retaining rural doctors: doctors’ preferences for rural medical workforce incentives. Soc Sci Med. 2014;121:56–64.CrossRef
Metadata
Title
Diagnostic delay in soft tissue tumors: a single-center study of a university cancer center with a focus on health services research
Authors
Tobias M. Ballhause
Alonja Reiter
Alexander Korthaus
Karl-Heinz Frosch
Carsten W. Schlickewei
Matthias H. Priemel
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2022
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-022-07891-w

Other articles of this Issue 1/2022

BMC Health Services Research 1/2022 Go to the issue